- Oops!Something went wrong.Please try again later.
As of late, it has definitely been a great time to be an investor in Crinetics Pharmaceuticals, Inc. CRNX. The stock has moved higher by 6.6% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.
We certainly think that this might be the case, particularly if you consider CRNX’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable; as CRNX has earned itself a Zacks Rank #2 (Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company. You can see the complete list of today’s Zacks #1 Rank stocks here.
5 Stocks to Soar Past the Pandemic: In addition to the companies you learned about above, we invite you to learn about 5 cutting-edge stocks that could skyrocket from the exponential increase in demand for “stay at home” technologies. This could be one of the biggest buying opportunities of the decade.
See the 5 high-tech stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Crinetics Pharmaceuticals, Inc. (CRNX) : Free Stock Analysis Report
To read this article on Zacks.com click here.